SOLIUS New World-class Talent and Scientific Leadership Team

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

GenesisCare Orders 27 Elekta Flexitron Treatment Devices

"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.

December 7, 2020

SOLIUS new world-class talent and scientific leadership team is led by technology and health care executive Bob Wise.

SOLIUS is focused on expanding its body of scientific validation through clinical trials, and recent additions to the medical advisory board align with this purpose. The company is working with leading experts in the fields of phototherapy and vitamin D research to develop its products and execute their trials.

The SOLIUS medical advisory board includes:

Dr. Ganesh Raghu from the University of Washington: Dr. Raghu is a board-certified physician at UW Medical Center, director of the UW Interstitial Lung Disease/Sarcoid/Pulmonary Fibrosis Program, and founder and former director of the UW Medicine Lung Transplant Program. He is board-certified in both Internal Medicine and Critical Care. Dr. Raghu’s 30+ years of research is devoted to both basic science (lung fibroblast and extracellular matrix) and translational and clinical studies in the field of pulmonary fibrosis, idiopathic interstitial pneumonia, and sarcoid.

Dr. Frank Lau from Louisiana State University: Dr. Lau is an Associate Professor of Clinical Surgery at LSU. He is the principal investigator of a tissue engineering and breast cancer research lab and is the recipient of 18 grants. His research interests include breast cancer, vitamin D insufficiency in COVID-19, incisional hernia prevention, pyoderma gangrenosum, regenerative approaches to limb salvage, and diseases of white adipose tissue.

Dr. Jan Dutz from the University of British Columbia: Dr. Dutz is a rheumatologist and dermatologist with a special clinical interest in the cutaneous manifestations of autoimmunity and rheumatic disease. His research focus is on the skin immune system and the manipulation of this system to promote immune responses and induce tolerance.

Dr. Michael Holick from Boston University: Dr. Holick is the Director of the General Clinical Research Unit, Bone Health Care Clinic, and Vitamin D, Skin and Bone Research Laboratory at Boston University. Dr. Holick has made numerous contributions to the field of the biochemistry, physiology, metabolism, and photobiology of vitamin D for human nutrition. He has established global recommendations advising sunlight exposure as an integral source of vitamin D and helped increase awareness in the medical community regarding the vitamin D deficiency pandemic, and its role not only in causing metabolic bone disease and osteoporosis but in an increased risk of developing multiple diseases.

On the executive team, the company has brought on Dr. Jashin Wu to serve as Chief Medical Officer. Dr. Wu is a dermatologist specializing in the treatment of psoriasis and is experienced in treating patients using light therapy. Dr. Wu is the founder and Course Director of the San Diego Dermatology Symposium and is the founder and CEO of the Dermatology Research and Education Foundation.

SOLIUS also added Rick White and Doug Hansmann to the board of directors. White served in the U.S. House of Representatives from 1995 to 1999, where he was known as one of Congress’s most active legislators on high-tech issues and is currently principal of the Woodbay Group where he focuses primarily on projects in the technology and public policy areas. Hansmann is a co-founder of EKOS Corporation and has been active as a bioengineer for several decades. He has a rich background in medical device product development and brings enormous expertise to the company.

Wise said, “Our team has never been more focused, and we are tremendously excited about the products we are developing and their impact on the health of everyone around us.”

View our full executive team, the board of directors, and medical advisory board here.



Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.